Valentina V. Matyushina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Valentina V. Matyushina has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Maksim Vital'EVich Menzorov
Ulyanovsk State University
5 shared publications - Aleksandr Mikhaylovich Shutov
Ulyanovsk State University
2 shared publications - Anna Yur'EVna Denisova
Ulyanovsk State University
2 shared publications - Maksim Vasil'EVich Gorbunov
Ulyanovsk State University
2 shared publications - Viktor Maksimovich Menzorov
Samara State Medical University
2 shared publications - Alexey D. Ehrlich
Pirogov Russian National Research Medical University
1 shared publication
Latest Publications
- 9 March 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 30 (1) , 72-80
Prognostic value of cystatin С in pulmonary embolism
BACKGROUND. Standard criteria allow diagnosing AKI within hours to days. The use of biomarkers is a promising approach for early diagnosis and prognosis of AKI. THE AIM: to study the capabilities of serum cystatin C (CYS) in the early diagnosis and prognosis of AKI and associated hospital mortality, the risk of 30-day death in pulmonary embolism (PE). PATIENTS (MATERILS) AND METHODS. 98 patients with suspected PE were included; patients were excluded if the diagnosis was not confirmed. CYS was determined on admission, the difference between the determined CYS and the estimated CYS corresponding to a glomerular filtration rate (GFR) of 75 ml/min/1.73 m2 (CYSdiff) and the difference between the GFR by CYS and the GFR by creatinine (eGFRdiff) were calculated. RESULTS. AKI was diagnosed in 13 of 63 patients with PE (men – 36(57 %), age – 67(12) years). In 7(54 %) cases, AKI was detected against the background of chronic kidney disease (CKD), in 6(46 %) – first-onset AKI. CYS>2.55 μg/ ml predicted AKI (sensitivity – 70 %, specificity – 62 %; AUC=0,70; p=0,01) and AKI in CKD patients (sensitivity – 86 %, specificity – 62 %; AUC=0,78; p=0,001). CYSdiff>1,62 μg/ml predicted AKI (sensitivity – 69 %, specificity – 68 %; AUC=0,70; p=0,01). 5 patients (9 %) died in hospital. Mortality was higher in AKI (χ2 =5.8; p=0,02). CYS, CYSdiff did not predict hospital mortality, while CYS>2,17 μg/ml (sensitivity – 70 %, specificity – 70 %; AUC=0,76; p=0,0001) and CYSdiff>1,22 μg/ml (sensitivity – 70 %, specificity – 70 %; AUC=0.77; p0,05). CONCLUSION. The results of the study confirm the effectiveness of CYS in the early diagnosis and prediction of AKI, including cases associated with CKD. The accuracy of prediction can be improved using CYSdiff. CYS does not predict in-hospital mortality but is associated with a high risk of 30-day death in PE.
- 9 March 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 30 (1) , 72-80
Prognostic value of cystatin С in pulmonary embolism
BACKGROUND. Standard criteria allow diagnosing AKI within hours to days. The use of biomarkers is a promising approach for early diagnosis and prognosis of AKI. THE AIM: to study the capabilities of serum cystatin C (CYS) in the early diagnosis and prognosis of AKI and associated hospital mortality, the risk of 30-day death in pulmonary embolism (PE). PATIENTS (MATERILS) AND METHODS. 98 patients with suspected PE were included; patients were excluded if the diagnosis was not confirmed. CYS was determined on admission, the difference between the determined CYS and the estimated CYS corresponding to a glomerular filtration rate (GFR) of 75 ml/min/1.73 m2 (CYSdiff) and the difference between the GFR by CYS and the GFR by creatinine (eGFRdiff) were calculated. RESULTS. AKI was diagnosed in 13 of 63 patients with PE (men – 36(57 %), age – 67(12) years). In 7(54 %) cases, AKI was detected against the background of chronic kidney disease (CKD), in 6(46 %) – first-onset AKI. CYS>2.55 μg/ ml predicted AKI (sensitivity – 70 %, specificity – 62 %; AUC=0,70; p=0,01) and AKI in CKD patients (sensitivity – 86 %, specificity – 62 %; AUC=0,78; p=0,001). CYSdiff>1,62 μg/ml predicted AKI (sensitivity – 69 %, specificity – 68 %; AUC=0,70; p=0,01). 5 patients (9 %) died in hospital. Mortality was higher in AKI (χ2 =5.8; p=0,02). CYS, CYSdiff did not predict hospital mortality, while CYS>2,17 μg/ml (sensitivity – 70 %, specificity – 70 %; AUC=0,76; p=0,0001) and CYSdiff>1,22 μg/ml (sensitivity – 70 %, specificity – 70 %; AUC=0.77; p0,05). CONCLUSION. The results of the study confirm the effectiveness of CYS in the early diagnosis and prediction of AKI, including cases associated with CKD. The accuracy of prediction can be improved using CYSdiff. CYS does not predict in-hospital mortality but is associated with a high risk of 30-day death in PE.
- Open Access
- 23 October 2025
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 65 (9) , 36-44
Prognostic Value of Cystatin C in Pulmonary Embolism
Aim To study a possibility of using serum concentrations of cystatin C (CYS) in early diagnosis and prediction of acute kidney injury (AKI) and associated in-hospital mortality and 30-day risk of death in pulmonary embolism (PE). Materials and methods This study included 98 patients with suspected PE, of whom 63 had a confirmed diagnosis and formed the study group; the rest were excluded. CYS was measured on admission. The difference (CYSdiff) between the measured CYS and the estimated CYS corresponding to the glomerular filtration rate (GFR) of 75 ml/min/1.73 m 2 was calculated using the reversed 2012 CKD-EPI Cystatin C formula. The estimated GFR was calculated as the difference between the CYS-based GFR (2012 CKD-EPI Cystatin C) and the creatinine-based GFR (2009 CKD-EPI). The 30-day mortality risk was assessed according to the ESC/ERS Guidelines for the diagnosis and treatment of acute PE in effect at the time of hospitalization. Results AKI was diagnosed in 13 (21%) of 63 patients with PE aged 67±12 years, of whom 36 (57%) were men. In 7 (54%) cases, AKI was associated with chronic kidney disease (CKD), and in 6 (46%) cases, AKI developed for the first time. The measurement of the CYS concentration ensured early diagnosis and prediction of AKI with AUC=0.70 (95% confidence interval (CI) 0.57-0.81; p =0.009), optimal cutoff point (OP) >2.55 μg/ml (sensitivity 70%, specificity 62%), and AKI associated with CKD with AUC=0.78 (95% CI 0.65-0.88; p =0.001), OP >2.55 μg/ml (sensitivity 86%, specificity 62%). Similar predictive value for AKI was determined for CYSdiff: AUC = 0.70 (95% CI 0.57-0.81; p =0.009), OP >1.62 μg/ml with a sensitivity of 69% and specificity of 68%. Five patients (9%) died in hospital. The death rate was higher in AKI (χ2 = 5.8; p =0.018). CYS and CYSdiff levels did not predict in-hospital mortality (p >0.05 for both). The predictive value of eGFRdiff was unsatisfactory for either AKI or mortality ( p >0.05 for both). It was found that CYS (AUC=0.76; 95% CI 0.63-0.85; p 2.17 μg/ml) with a sensitivity of 70%, specificity of 70%, and CYSdiff (AUC=0.77; 95% CI 0.64–0.86; p1.22 μg/ml) with a sensitivity of 70%, and specificity of 70%, but not eGFRdiff were associated with a high 30-day risk of death ( p =0.804). Conclusion The study results confirm the effectiveness of CYS assessment in the early diagnosis and prediction of AKI, including cases associated with CKD. Prediction accuracy can be improved using CYSdiff. CYS levels do not predict in-hospital mortality but are associated with a high 30-day risk of death in patients with PE.
- 23 October 2025
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 65 (9) , 36-44
Open AccessPrognostic Value of Cystatin C in Pulmonary Embolism
Aim To study a possibility of using serum concentrations of cystatin C (CYS) in early diagnosis and prediction of acute kidney injury (AKI) and associated in-hospital mortality and 30-day risk of death in pulmonary embolism (PE). Materials and methods This study included 98 patients with suspected PE, of whom 63 had a confirmed diagnosis and formed the study group; the rest were excluded. CYS was measured on admission. The difference (CYSdiff) between the measured CYS and the estimated CYS corresponding to the glomerular filtration rate (GFR) of 75 ml/min/1.73 m 2 was calculated using the reversed 2012 CKD-EPI Cystatin C formula. The estimated GFR was calculated as the difference between the CYS-based GFR (2012 CKD-EPI Cystatin C) and the creatinine-based GFR (2009 CKD-EPI). The 30-day mortality risk was assessed according to the ESC/ERS Guidelines for the diagnosis and treatment of acute PE in effect at the time of hospitalization. Results AKI was diagnosed in 13 (21%) of 63 patients with PE aged 67±12 years, of whom 36 (57%) were men. In 7 (54%) cases, AKI was associated with chronic kidney disease (CKD), and in 6 (46%) cases, AKI developed for the first time. The measurement of the CYS concentration ensured early diagnosis and prediction of AKI with AUC=0.70 (95% confidence interval (CI) 0.57-0.81; p =0.009), optimal cutoff point (OP) >2.55 μg/ml (sensitivity 70%, specificity 62%), and AKI associated with CKD with AUC=0.78 (95% CI 0.65-0.88; p =0.001), OP >2.55 μg/ml (sensitivity 86%, specificity 62%). Similar predictive value for AKI was determined for CYSdiff: AUC = 0.70 (95% CI 0.57-0.81; p =0.009), OP >1.62 μg/ml with a sensitivity of 69% and specificity of 68%. Five patients (9%) died in hospital. The death rate was higher in AKI (χ2 = 5.8; p =0.018). CYS and CYSdiff levels did not predict in-hospital mortality (p >0.05 for both). The predictive value of eGFRdiff was unsatisfactory for either AKI or mortality ( p >0.05 for both). It was found that CYS (AUC=0.76; 95% CI 0.63-0.85; p 2.17 μg/ml) with a sensitivity of 70%, specificity of 70%, and CYSdiff (AUC=0.77; 95% CI 0.64–0.86; p1.22 μg/ml) with a sensitivity of 70%, and specificity of 70%, but not eGFRdiff were associated with a high 30-day risk of death ( p =0.804). Conclusion The study results confirm the effectiveness of CYS assessment in the early diagnosis and prediction of AKI, including cases associated with CKD. Prediction accuracy can be improved using CYSdiff. CYS levels do not predict in-hospital mortality but are associated with a high 30-day risk of death in patients with PE.
- Open Access
- 27 November 2024
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 105 (6) , 994-1002
The concept of acute kidney disease and its place in the renal continuum
The paper discusses the concept of acute kidney disease, a relatively new concept in clinical medicine, the introduction of which is due to the presence of kidney diseases that do not meet strict criteria for acute kidney injury or chronic kidney disease. The article presents the criteria and severity stratification of acute kidney disease proposed by the Kidney Disease: Improving Global Outcomes Foundation, interpretation of the criteria and severity stratification by the Scientific Society of Nephrologists of Russia, associations of nephrologists and anesthesiologists-resuscitators of Russia, the National Society of Specialists in Hemapheresis and Extracorporeal Hemocorrection in accordance with the classification system of the Acute Dialysis Quality Initiative group. The role of acute kidney disease in the modern renal continuum is outlined. The article reviews the results of studies of acute kidney disease in patients with septic shock, patients who underwent total joint replacement, myocardial infarction with ST segment elevation and having acute kidney injury, patients with ischemic stroke, after coronary angiography, after acute surgery for type A aortic dissection, which demonstrate the prevalence of acute kidney disease and its outcomes. Despite the fact that acute kidney disease has a high prevalence among patients with various pathologies, worsens the prognosis and increases the risk of death or complications, its significance in modern medicine remains extremely underestimated. The article identifies the most common and studied biochemical markers that can potentially increase the proportion of patients at risk of adverse outcomes when used in clinical practice.
- 27 November 2024
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 105 (6) , 994-1002
Open AccessThe concept of acute kidney disease and its place in the renal continuum
The paper discusses the concept of acute kidney disease, a relatively new concept in clinical medicine, the introduction of which is due to the presence of kidney diseases that do not meet strict criteria for acute kidney injury or chronic kidney disease. The article presents the criteria and severity stratification of acute kidney disease proposed by the Kidney Disease: Improving Global Outcomes Foundation, interpretation of the criteria and severity stratification by the Scientific Society of Nephrologists of Russia, associations of nephrologists and anesthesiologists-resuscitators of Russia, the National Society of Specialists in Hemapheresis and Extracorporeal Hemocorrection in accordance with the classification system of the Acute Dialysis Quality Initiative group. The role of acute kidney disease in the modern renal continuum is outlined. The article reviews the results of studies of acute kidney disease in patients with septic shock, patients who underwent total joint replacement, myocardial infarction with ST segment elevation and having acute kidney injury, patients with ischemic stroke, after coronary angiography, after acute surgery for type A aortic dissection, which demonstrate the prevalence of acute kidney disease and its outcomes. Despite the fact that acute kidney disease has a high prevalence among patients with various pathologies, worsens the prognosis and increases the risk of death or complications, its significance in modern medicine remains extremely underestimated. The article identifies the most common and studied biochemical markers that can potentially increase the proportion of patients at risk of adverse outcomes when used in clinical practice.
- Open Access
- 17 March 2022
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (1S) , 4864
Incidence and prognostic value of acute kidney injury in pulmonary embolism: data from the SIRENA registry
Aim. To evaluate the incidence and severity of acute kidney injury (AKI), as well as its ability to reclassify the risk of premature mortality and association with inhospital mortality in patients with pulmonary embolism (PE) in the Russian population.Material and methods. From April 2018 to April 2019, the SIRENA Russian Multicenter Registry included patients with PE, as well as the deceased, in whom the PE was detected by autopsy. AKI was diagnosed according to current KDIGO guidelines (2012). Creatinine calculated according to the MDRD equation and corresponding to a glomerular filtration rate of 75 ml/min/1,73 m2 (baseline) was taken as the initial one, with subsequent assessment relative to the parameter value upon admission. The risk stratification of early death was carried out in accordance with the current ESC clinical guidelines (2019).Results. A total of 604 patients with PE were examined (men — 293 (49%), women — 311 (51%), mean age — 64±15 years). AKI was diagnosed in 223 (37%) of them. Stage 1 AKI was detected in 146 (65%), 2 — in 55 (25%), 3 — in 22 (10%) patients. Prior chronic kidney disease was recorded in 61 (10%) patients. Seventy-one (12%) patients had a high risk of death, 364 (61%) — intermediate risk, and 164 (27%) — low risk. The AKI incidence increased as the severity of PE increased: at low risk of death — 26%, intermediate — 38%, high — 59% (pConclusion. Thirty-seven percent of Russian patients with PE have AKI diagnosed by baseline creatinine. In 2/3 of the examined patients, stage 1 AKI is observed. The AKI incidence increases as the severity of PE increases. The presence of AKI reclassifies patients into a higher risk category for death and is associated with a significant increase in inhospital mortality.
- 17 March 2022
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (1S) , 4864
Open AccessIncidence and prognostic value of acute kidney injury in pulmonary embolism: data from the SIRENA registry
Aim. To evaluate the incidence and severity of acute kidney injury (AKI), as well as its ability to reclassify the risk of premature mortality and association with inhospital mortality in patients with pulmonary embolism (PE) in the Russian population.Material and methods. From April 2018 to April 2019, the SIRENA Russian Multicenter Registry included patients with PE, as well as the deceased, in whom the PE was detected by autopsy. AKI was diagnosed according to current KDIGO guidelines (2012). Creatinine calculated according to the MDRD equation and corresponding to a glomerular filtration rate of 75 ml/min/1,73 m2 (baseline) was taken as the initial one, with subsequent assessment relative to the parameter value upon admission. The risk stratification of early death was carried out in accordance with the current ESC clinical guidelines (2019).Results. A total of 604 patients with PE were examined (men — 293 (49%), women — 311 (51%), mean age — 64±15 years). AKI was diagnosed in 223 (37%) of them. Stage 1 AKI was detected in 146 (65%), 2 — in 55 (25%), 3 — in 22 (10%) patients. Prior chronic kidney disease was recorded in 61 (10%) patients. Seventy-one (12%) patients had a high risk of death, 364 (61%) — intermediate risk, and 164 (27%) — low risk. The AKI incidence increased as the severity of PE increased: at low risk of death — 26%, intermediate — 38%, high — 59% (pConclusion. Thirty-seven percent of Russian patients with PE have AKI diagnosed by baseline creatinine. In 2/3 of the examined patients, stage 1 AKI is observed. The AKI incidence increases as the severity of PE increases. The presence of AKI reclassifies patients into a higher risk category for death and is associated with a significant increase in inhospital mortality.
- 30 July 2021
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
ACUTE KIDNEY INJURY IN PATIENTS WITH PULMONARY ARTERY THROMBOEMBOLIA
The aim of the study is to diagnose acute kidney injury, its severity, and types in patients with pulmonary artery thromboembolia (PATE), to establish the correlation between AKI and the estimated mortality risk, hospital mortality. Materials and Methods. The study enrolled 111 patients (61 males (55 %), and 50 females (45 %), average age 66.8±11.7 years) with PATE, hospitalized to the cardiology department of Ulyanovsk Central City Clinical Hospital. Results. Acute kidney injury was diagnosed in 36 patients with PATE (34 %): among them 24 patients with stage 1 PATE (67 %); 7 patients with stage 2 (19 %); 5 patients with stage 3 (14 %). Prehospital complications were diagnosed in 20 patients (56 %), hospital AKI was detected in 16 patients (44 %). CKD-associated AKI was observed in 24 patients (67 %), de novo AKI was diagnosed in 12 trial subjects (33 %). Twenty-six patients (23 %) died during hospitalization. The relative hospital mortality risk in AKI patients was 5.2 (95 % CI: 2.02–13.39; p<0.001). The estimated risk of 30-day mortality according to the PESI score was higher in AKI patients (120.0 (87.5–158,0) and 90 (87.5-158.0), respectively, p=0.004). Conclusion. Patients with PATE had a high incidence of AKI, which was diagnosed in every 3rd patient. In 67 % of patients, AKI was associated with chronic kidney disease. Patients with prehospital AKI prevailed (56 %). AKI in patients with PATE was associated with increased in-hospital mortality and an estimated 30-day mortality risk. Keywords: acute kidney injury, pulmonary embolism, hospital mortality, estimated mortality risk. Цель исследования. Оценить наличие, степень выраженности и варианты острого повреждения почек (ОПП) у пациентов с тромбоэмболией легочной артерии (ТЭЛА); уточнить связь между ОПП и расчетным риском смерти, госпитальной летальностью. Материалы и методы. Обследовано 111 пациентов (мужчин – 61 (55 %), женщин – 50 (45 %), средний возраст – 66,8±11,7 года) с ТЭЛА, госпитализированных в отделение кардиологии ГУЗ «Центральная городская клиническая больница г. Ульяновска». Результаты. Острое повреждение почек диагностировано у 36 (34 %) пациентов с ТЭЛА, причем у 24 (67 %) из них выявлена 1 стадия, у 7 (19 %) – 2 стадия и у 5 (14 %) – 3 стадия. У 20 (56 %) пациентов диагностирован догоспитальный вариант осложнения, госпитальное ОПП выявлялось в 16 (44 %) случаях. ОПП при ХБП имело место у 24 (67 %) обследованных, ОПП de novo – у 12 (33 %). В период госпитализации умерло 26 (23 %) пациентов. Относительный риск смерти в стационаре у пациентов с ОПП составил 5,2 (95 % ДИ: 2,02–13,39; р<0,001). Расчетный риск 30-дневной смерти по шкале PESI при наличии ОПП был выше, чем при его отсутствии (120,0 (87,5–158,0) и 90 (87,5–158,0) соответственно, p=0,004). Выводы. У пациентов с ТЭЛА наблюдается высокая частота ОПП, оно диагностируется у каждого 3-го пациента. У 67 % пациентов острое повреждение почек развивается на фоне предшествующей хронической болезни почек. Преобладают пациенты с догоспитальным ОПП (56 %). Острое повреждение почек у пациентов с ТЭЛА ассоциировано с увеличением госпитальной летальности и расчетного риска 30-дневной смертности. Ключевые слова: острое повреждение почек, тромбоэмболия легочной артерии, госпитальная летальность, расчетный риск смерти.
- 30 July 2021
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
ACUTE KIDNEY INJURY IN PATIENTS WITH PULMONARY ARTERY THROMBOEMBOLIA
The aim of the study is to diagnose acute kidney injury, its severity, and types in patients with pulmonary artery thromboembolia (PATE), to establish the correlation between AKI and the estimated mortality risk, hospital mortality. Materials and Methods. The study enrolled 111 patients (61 males (55 %), and 50 females (45 %), average age 66.8±11.7 years) with PATE, hospitalized to the cardiology department of Ulyanovsk Central City Clinical Hospital. Results. Acute kidney injury was diagnosed in 36 patients with PATE (34 %): among them 24 patients with stage 1 PATE (67 %); 7 patients with stage 2 (19 %); 5 patients with stage 3 (14 %). Prehospital complications were diagnosed in 20 patients (56 %), hospital AKI was detected in 16 patients (44 %). CKD-associated AKI was observed in 24 patients (67 %), de novo AKI was diagnosed in 12 trial subjects (33 %). Twenty-six patients (23 %) died during hospitalization. The relative hospital mortality risk in AKI patients was 5.2 (95 % CI: 2.02–13.39; p<0.001). The estimated risk of 30-day mortality according to the PESI score was higher in AKI patients (120.0 (87.5–158,0) and 90 (87.5-158.0), respectively, p=0.004). Conclusion. Patients with PATE had a high incidence of AKI, which was diagnosed in every 3rd patient. In 67 % of patients, AKI was associated with chronic kidney disease. Patients with prehospital AKI prevailed (56 %). AKI in patients with PATE was associated with increased in-hospital mortality and an estimated 30-day mortality risk. Keywords: acute kidney injury, pulmonary embolism, hospital mortality, estimated mortality risk. Цель исследования. Оценить наличие, степень выраженности и варианты острого повреждения почек (ОПП) у пациентов с тромбоэмболией легочной артерии (ТЭЛА); уточнить связь между ОПП и расчетным риском смерти, госпитальной летальностью. Материалы и методы. Обследовано 111 пациентов (мужчин – 61 (55 %), женщин – 50 (45 %), средний возраст – 66,8±11,7 года) с ТЭЛА, госпитализированных в отделение кардиологии ГУЗ «Центральная городская клиническая больница г. Ульяновска». Результаты. Острое повреждение почек диагностировано у 36 (34 %) пациентов с ТЭЛА, причем у 24 (67 %) из них выявлена 1 стадия, у 7 (19 %) – 2 стадия и у 5 (14 %) – 3 стадия. У 20 (56 %) пациентов диагностирован догоспитальный вариант осложнения, госпитальное ОПП выявлялось в 16 (44 %) случаях. ОПП при ХБП имело место у 24 (67 %) обследованных, ОПП de novo – у 12 (33 %). В период госпитализации умерло 26 (23 %) пациентов. Относительный риск смерти в стационаре у пациентов с ОПП составил 5,2 (95 % ДИ: 2,02–13,39; р<0,001). Расчетный риск 30-дневной смерти по шкале PESI при наличии ОПП был выше, чем при его отсутствии (120,0 (87,5–158,0) и 90 (87,5–158,0) соответственно, p=0,004). Выводы. У пациентов с ТЭЛА наблюдается высокая частота ОПП, оно диагностируется у каждого 3-го пациента. У 67 % пациентов острое повреждение почек развивается на фоне предшествующей хронической болезни почек. Преобладают пациенты с догоспитальным ОПП (56 %). Острое повреждение почек у пациентов с ТЭЛА ассоциировано с увеличением госпитальной летальности и расчетного риска 30-дневной смертности. Ключевые слова: острое повреждение почек, тромбоэмболия легочной артерии, госпитальная летальность, расчетный риск смерти.